- Published on
Ophthalmology – Acute Bacterial Conjunctivitis
Acute bacterial conjunctivitis is a common inflammation of the conjunctiva, the mucous membrane lining the inner eyelids and covering the sclera. It affects individuals of all ages and is particularly frequent in children, where bacteria account for the majority of infectious conjunctivitis cases. The condition is highly contagious and represents a significant portion of primary care and ophthalmology visits.
Patients typically present with a red eye accompanied by purulent (yellow-green) discharge, which often leads to eyelid crusting or “glued eyes” upon waking. Symptoms frequently involve both eyes, though one eye may be affected first. Other features include irritation, tearing, and mild discomfort. Unlike viral conjunctivitis, watery discharge is less prominent, and severe pain or vision loss should prompt evaluation for alternative diagnoses. In hyperacute cases—most notably caused by Neisseria gonorrhoeae—patients may develop copious discharge and rapid progression, posing a risk for corneal damage.
The most common causative organisms include Staphylococcus aureus (more common in adults), Haemophilus influenzae and Streptococcus pneumoniae (common in children), and Moraxella catarrhalis. Chronic cases may be caused by Chlamydia, while hyperacute cases are associated with gonococcal infection. Risk factors include close contact with infected individuals, sinusitis, and immunocompromised states.
Diagnosis is usually clinical, though it can be challenging to distinguish from viral conjunctivitis based on symptoms alone. On examination, findings may include conjunctival injection, papillary reaction, and purulent discharge. Preauricular lymphadenopathy is uncommon in bacterial cases. Laboratory testing (culture or Gram stain) is reserved for severe, recurrent, or nonresponsive cases, or when gonococcal or chlamydial infection is suspected.
Treatment typically involves topical antibiotics, which shorten the duration of symptoms and reduce transmission. First-line options include trimethoprim-polymyxin B or fluoroquinolone eye drops for about 7 days. Hyperacute gonococcal conjunctivitis requires systemic antibiotics such as intramuscular ceftriaxone, often combined with topical therapy and close follow-up due to the risk of corneal ulceration and perforation. Supportive care includes artificial tears, good hygiene, and avoidance of sharing personal items.
The prognosis is excellent, as most cases are self-limiting, even without treatment. However, antibiotics speed recovery and reduce spread. Patients should be advised that they remain contagious for 24–48 hours after starting antibiotics. Follow-up is recommended if symptoms worsen, vision decreases, or there is no improvement within a week. Complications are rare but may include keratitis in severe or untreated cases.
Acute bacterial conjunctivitis is a common inflammation of the conjunctiva, the mucous membrane lining the inner eyelids and covering the sclera. It affects individuals of all ages and is particularly frequent in children, where bacteria account for the majority of infectious conjunctivitis cases. The condition is highly contagious and represents a significant portion of primary care and ophthalmology visits.
Patients typically present with a red eye accompanied by purulent (yellow-green) discharge, which often leads to eyelid crusting or “glued eyes” upon waking. Symptoms frequently involve both eyes, though one eye may be affected first. Other features include irritation, tearing, and mild discomfort. Unlike viral conjunctivitis, watery discharge is less prominent, and severe pain or vision loss should prompt evaluation for alternative diagnoses. In hyperacute cases—most notably caused by Neisseria gonorrhoeae—patients may develop copious discharge and rapid progression, posing a risk for corneal damage.
The most common causative organisms include Staphylococcus aureus (more common in adults), Haemophilus influenzae and Streptococcus pneumoniae (common in children), and Moraxella catarrhalis. Chronic cases may be caused by Chlamydia, while hyperacute cases are associated with gonococcal infection. Risk factors include close contact with infected individuals, sinusitis, and immunocompromised states.
Diagnosis is usually clinical, though it can be challenging to distinguish from viral conjunctivitis based on symptoms alone. On examination, findings may include conjunctival injection, papillary reaction, and purulent discharge. Preauricular lymphadenopathy is uncommon in bacterial cases. Laboratory testing (culture or Gram stain) is reserved for severe, recurrent, or nonresponsive cases, or when gonococcal or chlamydial infection is suspected.
Treatment typically involves topical antibiotics, which shorten the duration of symptoms and reduce transmission. First-line options include trimethoprim-polymyxin B or fluoroquinolone eye drops for about 7 days. Hyperacute gonococcal conjunctivitis requires systemic antibiotics such as intramuscular ceftriaxone, often combined with topical therapy and close follow-up due to the risk of corneal ulceration and perforation. Supportive care includes artificial tears, good hygiene, and avoidance of sharing personal items.
The prognosis is excellent, as most cases are self-limiting, even without treatment. However, antibiotics speed recovery and reduce spread. Patients should be advised that they remain contagious for 24–48 hours after starting antibiotics. Follow-up is recommended if symptoms worsen, vision decreases, or there is no improvement within a week. Complications are rare but may include keratitis in severe or untreated cases.
- Published on
Ophthalmology – Conjunctival Primary Acquired Melanosis (PAM)
Conjunctival primary acquired melanosis (PAM) is an acquired, flat pigmentation of the conjunctiva that typically develops in middle-aged or older adults, most often in individuals with lighter skin. It is usually unilateral, nonhereditary, and slowly progressive, and can involve multiple regions of the conjunctiva including the limbus, bulbar surface, fornix, caruncle, and even the tarsal conjunctiva. Unlike conjunctival melanoma, PAM generally lacks prominent vascularity and appears as a patchy, brown discoloration of the ocular surface.
The clinical importance of PAM lies in its potential to act as a precursor to conjunctival melanoma, particularly when atypia is present. Patients often report a gradually enlarging pigmented area on the eye, although many remain asymptomatic. The condition is more common in Caucasians and has been associated with sunlight exposure, though no single definitive risk factor has been identified.
Pathophysiologically, PAM begins as melanocytic proliferation in the basal layer of the conjunctival epithelium. In cases with atypia, these abnormal melanocytes can extend upward through the epithelial layers and eventually penetrate the basement membrane, transforming into invasive melanoma. Histologically, PAM is classified into two main types: without atypia (benign) and with atypia (premalignant). The risk of progression to melanoma is negligible in PAM without atypia but increases significantly with atypia—especially severe atypia, where transformation risk can be very high.
Diagnosis is primarily clinical, supported by careful slit-lamp examination and documentation of lesion extent (often measured in clock hours). Imaging such as anterior segment OCT may help confirm that the lesion is superficial without deeper invasion. In selected cases, biopsy or cytologic evaluation may be performed to assess for atypia, although some clinicians prefer to proceed directly to treatment without prior manipulation.
Management depends on the extent and histologic features of the lesion. Small areas may be observed, especially if atypia is not suspected. More extensive or suspicious lesions are typically treated with surgical excision combined with cryotherapy to surrounding tissue. For diffuse or recurrent disease, topical chemotherapy agents such as mitomycin C may be used, and in extensive cases, even radiotherapy can be considered. The goal is to eliminate abnormal pigmentation and reduce the risk of malignant transformation.
Lifelong follow-up is essential. Patients are usually monitored every 3–4 months initially, then every 6 months once stability is established. Regular examinations focus on detecting growth, recurrence, or transformation into melanoma.
The prognosis is excellent if PAM remains non-atypical. However, once transformation to melanoma occurs, the prognosis becomes more guarded due to the risk of metastasis. Complications from treatment may include ocular surface issues such as dry eye, scarring, symblepharon, and, rarely, vision loss, particularly in advanced or extensively treated cases.
Conjunctival primary acquired melanosis (PAM) is an acquired, flat pigmentation of the conjunctiva that typically develops in middle-aged or older adults, most often in individuals with lighter skin. It is usually unilateral, nonhereditary, and slowly progressive, and can involve multiple regions of the conjunctiva including the limbus, bulbar surface, fornix, caruncle, and even the tarsal conjunctiva. Unlike conjunctival melanoma, PAM generally lacks prominent vascularity and appears as a patchy, brown discoloration of the ocular surface.
The clinical importance of PAM lies in its potential to act as a precursor to conjunctival melanoma, particularly when atypia is present. Patients often report a gradually enlarging pigmented area on the eye, although many remain asymptomatic. The condition is more common in Caucasians and has been associated with sunlight exposure, though no single definitive risk factor has been identified.
Pathophysiologically, PAM begins as melanocytic proliferation in the basal layer of the conjunctival epithelium. In cases with atypia, these abnormal melanocytes can extend upward through the epithelial layers and eventually penetrate the basement membrane, transforming into invasive melanoma. Histologically, PAM is classified into two main types: without atypia (benign) and with atypia (premalignant). The risk of progression to melanoma is negligible in PAM without atypia but increases significantly with atypia—especially severe atypia, where transformation risk can be very high.
Diagnosis is primarily clinical, supported by careful slit-lamp examination and documentation of lesion extent (often measured in clock hours). Imaging such as anterior segment OCT may help confirm that the lesion is superficial without deeper invasion. In selected cases, biopsy or cytologic evaluation may be performed to assess for atypia, although some clinicians prefer to proceed directly to treatment without prior manipulation.
Management depends on the extent and histologic features of the lesion. Small areas may be observed, especially if atypia is not suspected. More extensive or suspicious lesions are typically treated with surgical excision combined with cryotherapy to surrounding tissue. For diffuse or recurrent disease, topical chemotherapy agents such as mitomycin C may be used, and in extensive cases, even radiotherapy can be considered. The goal is to eliminate abnormal pigmentation and reduce the risk of malignant transformation.
Lifelong follow-up is essential. Patients are usually monitored every 3–4 months initially, then every 6 months once stability is established. Regular examinations focus on detecting growth, recurrence, or transformation into melanoma.
The prognosis is excellent if PAM remains non-atypical. However, once transformation to melanoma occurs, the prognosis becomes more guarded due to the risk of metastasis. Complications from treatment may include ocular surface issues such as dry eye, scarring, symblepharon, and, rarely, vision loss, particularly in advanced or extensively treated cases.
- Published on
Ophthalmology – Conjunctival Nevus
Conjunctival nevus is the most common conjunctival tumor, accounting for a large proportion of melanocytic lesions of the ocular surface. It is typically a benign proliferation of melanocytes and may be present at birth (congenital) or develop during childhood or adolescence. Most lesions become clinically noticeable in the first or second decade of life and can change in pigmentation over time, particularly during periods of hormonal change such as puberty.
Clinically, conjunctival nevi appear as well-defined, slightly elevated lesions that may be pigmented (brown) or amelanotic (nonpigmented). A key distinguishing feature is the presence of intralesional cysts, which are often visible on slit-lamp examination and help differentiate nevi from malignant lesions. These lesions are most commonly located on the bulbar conjunctiva, especially near the nasal or temporal limbus in sun-exposed areas. Importantly, they usually do not extend onto the cornea and tend to move with the conjunctiva.
Most patients are asymptomatic and simply notice a “spot on the eye.” Occasionally, mild irritation or inflammation may occur. The condition is generally sporadic and rarely associated with systemic disease, although uncommon associations with syndromes like Carney complex have been reported.
Diagnosis is primarily clinical, supported by slit-lamp examination and photographic documentation. Anterior segment OCT can help identify cystic components within the lesion. Regular follow-up with serial photography every 6–12 months is recommended to monitor for changes in size, shape, or pigmentation.
Management is usually conservative. Observation is the standard approach for typical, stable lesions. However, surgical excision may be indicated if there are suspicious features such as documented growth, absence of cysts, prominent feeder vessels, unusual location (e.g., forniceal or tarsal conjunctiva), corneal involvement, or onset later in life. Excision is performed using a “no-touch” technique with cryotherapy to margins to reduce the risk of recurrence or malignant transformation.
The prognosis is excellent in the vast majority of cases, as conjunctival nevi are benign. Malignant transformation into melanoma is rare but possible, which is why periodic monitoring is essential. Complications are uncommon but may include mild irritation or dry eye following surgical removal.
Conjunctival nevus is the most common conjunctival tumor, accounting for a large proportion of melanocytic lesions of the ocular surface. It is typically a benign proliferation of melanocytes and may be present at birth (congenital) or develop during childhood or adolescence. Most lesions become clinically noticeable in the first or second decade of life and can change in pigmentation over time, particularly during periods of hormonal change such as puberty.
Clinically, conjunctival nevi appear as well-defined, slightly elevated lesions that may be pigmented (brown) or amelanotic (nonpigmented). A key distinguishing feature is the presence of intralesional cysts, which are often visible on slit-lamp examination and help differentiate nevi from malignant lesions. These lesions are most commonly located on the bulbar conjunctiva, especially near the nasal or temporal limbus in sun-exposed areas. Importantly, they usually do not extend onto the cornea and tend to move with the conjunctiva.
Most patients are asymptomatic and simply notice a “spot on the eye.” Occasionally, mild irritation or inflammation may occur. The condition is generally sporadic and rarely associated with systemic disease, although uncommon associations with syndromes like Carney complex have been reported.
Diagnosis is primarily clinical, supported by slit-lamp examination and photographic documentation. Anterior segment OCT can help identify cystic components within the lesion. Regular follow-up with serial photography every 6–12 months is recommended to monitor for changes in size, shape, or pigmentation.
Management is usually conservative. Observation is the standard approach for typical, stable lesions. However, surgical excision may be indicated if there are suspicious features such as documented growth, absence of cysts, prominent feeder vessels, unusual location (e.g., forniceal or tarsal conjunctiva), corneal involvement, or onset later in life. Excision is performed using a “no-touch” technique with cryotherapy to margins to reduce the risk of recurrence or malignant transformation.
The prognosis is excellent in the vast majority of cases, as conjunctival nevi are benign. Malignant transformation into melanoma is rare but possible, which is why periodic monitoring is essential. Complications are uncommon but may include mild irritation or dry eye following surgical removal.
- Published on
Ophthalmology – Conjunctival and Corneal Lacerations
Conjunctival and corneal lacerations are tears or cuts of the ocular surface caused by blunt or penetrating trauma. These injuries range from superficial partial-thickness defects to full-thickness open globe injuries, which are vision-threatening emergencies. They are more common in young males and are frequently associated with occupational or recreational activities where protective eyewear is not used.
Patients typically present with pain, redness, tearing, photophobia, and foreign body sensation. A careful history is critical, especially regarding the mechanism of injury, as high-velocity trauma (e.g., metal-on-metal or BB gun injuries) raises strong concern for intraocular foreign body (IOFB) or globe rupture. Determining the timing of last oral intake is also important if urgent surgery is required.
On examination, minimal manipulation of the eye is essential to avoid worsening a possible open globe injury. Visual acuity should always be checked, but intraocular pressure must not be measured if a full-thickness laceration is suspected. Slit-lamp examination helps assess the size, depth, and location of the wound. Fluorescein staining can highlight epithelial defects, and a positive Seidel test confirms aqueous leakage, indicating a full-thickness laceration. Additional concerning signs include irregular pupil, shallow or deep anterior chamber, hyphema, hypotony, or vitreous hemorrhage. Both eyes must be examined carefully, and eyelid eversion should be performed when safe.
If an intraocular foreign body is suspected, orbital CT scan (thin cuts) is the imaging modality of choice, while MRI should be avoided if metallic material is possible. Even with normal imaging, persistent suspicion of globe injury may require surgical exploration.
Management depends on the severity of the injury. Small conjunctival lacerations without scleral involvement often heal with topical antibiotic ointment alone, while larger ones may require suturing. Partial-thickness corneal lacerations are treated with topical antibiotics and close observation, though some may need suturing if wound edges gape. In contrast, full-thickness corneal lacerations are ophthalmic emergencies requiring urgent surgical repair in the operating room. Patients should be protected with a rigid eye shield, kept NPO, and given systemic antibiotics to reduce infection risk. Antiemetics and pain control are important to prevent increases in intraocular pressure.
Surgical repair focuses on restoring globe integrity, carefully repositioning tissues, removing vitreous traction if present, and achieving watertight closure using fine sutures. Associated injuries such as traumatic cataract or iris damage are usually addressed later. Patients must be counseled about the rare but serious risk of sympathetic ophthalmia, which can affect the uninjured eye.
Close follow-up is required to monitor for complications such as infection, retinal detachment, or wound leakage. Children are at particular risk of amblyopia, requiring prompt visual rehabilitation. Prognosis varies widely depending on the severity of injury, timing of treatment, and presence of complications, with worse outcomes associated with delayed care or severe trauma.
Conjunctival and corneal lacerations are tears or cuts of the ocular surface caused by blunt or penetrating trauma. These injuries range from superficial partial-thickness defects to full-thickness open globe injuries, which are vision-threatening emergencies. They are more common in young males and are frequently associated with occupational or recreational activities where protective eyewear is not used.
Patients typically present with pain, redness, tearing, photophobia, and foreign body sensation. A careful history is critical, especially regarding the mechanism of injury, as high-velocity trauma (e.g., metal-on-metal or BB gun injuries) raises strong concern for intraocular foreign body (IOFB) or globe rupture. Determining the timing of last oral intake is also important if urgent surgery is required.
On examination, minimal manipulation of the eye is essential to avoid worsening a possible open globe injury. Visual acuity should always be checked, but intraocular pressure must not be measured if a full-thickness laceration is suspected. Slit-lamp examination helps assess the size, depth, and location of the wound. Fluorescein staining can highlight epithelial defects, and a positive Seidel test confirms aqueous leakage, indicating a full-thickness laceration. Additional concerning signs include irregular pupil, shallow or deep anterior chamber, hyphema, hypotony, or vitreous hemorrhage. Both eyes must be examined carefully, and eyelid eversion should be performed when safe.
If an intraocular foreign body is suspected, orbital CT scan (thin cuts) is the imaging modality of choice, while MRI should be avoided if metallic material is possible. Even with normal imaging, persistent suspicion of globe injury may require surgical exploration.
Management depends on the severity of the injury. Small conjunctival lacerations without scleral involvement often heal with topical antibiotic ointment alone, while larger ones may require suturing. Partial-thickness corneal lacerations are treated with topical antibiotics and close observation, though some may need suturing if wound edges gape. In contrast, full-thickness corneal lacerations are ophthalmic emergencies requiring urgent surgical repair in the operating room. Patients should be protected with a rigid eye shield, kept NPO, and given systemic antibiotics to reduce infection risk. Antiemetics and pain control are important to prevent increases in intraocular pressure.
Surgical repair focuses on restoring globe integrity, carefully repositioning tissues, removing vitreous traction if present, and achieving watertight closure using fine sutures. Associated injuries such as traumatic cataract or iris damage are usually addressed later. Patients must be counseled about the rare but serious risk of sympathetic ophthalmia, which can affect the uninjured eye.
Close follow-up is required to monitor for complications such as infection, retinal detachment, or wound leakage. Children are at particular risk of amblyopia, requiring prompt visual rehabilitation. Prognosis varies widely depending on the severity of injury, timing of treatment, and presence of complications, with worse outcomes associated with delayed care or severe trauma.
- Published on
Ophthalmology – Congenital and Pediatric Cataracts
Congenital and pediatric cataracts refer to any opacity of the crystalline lens present at birth or developing during childhood. These cataracts may occur in isolation or in association with ocular abnormalities or systemic disease. Their morphology is highly variable, including forms such as anterior polar, lamellar, nuclear, posterior lenticonus, cerulean, sutural, and total cataracts.
In approximately 60–70% of cases, a cause can be identified, most commonly genetic. The condition may be unilateral or bilateral and can significantly impact visual development if not detected early.
The incidence in the United States is estimated at 1.2–6 per 10,000 children. Risk factors include intrauterine infections, metabolic disorders, trauma (including birth trauma), steroid exposure, uveitis, genetic syndromes, and family history.
Genetically, the most common inheritance pattern is autosomal dominant with variable penetrance, although autosomal recessive and X-linked forms also occur. Numerous genes have been implicated, reflecting the heterogeneity of this condition.
Pathophysiologically, cataract formation results from disruption of normal lens development or metabolism, leading to loss of transparency. The location and type of opacity often reflect the timing of the insult during fetal development or early life.
Etiologies include:
• Idiopathic (most common)
• Genetic mutations
• Intrauterine infections (e.g., Congenital rubella syndrome, toxoplasmosis, CMV, herpes)
• Metabolic disorders such as Galactosemia
• Chromosomal abnormalities (e.g., trisomy 21)
• Drug exposure (e.g., corticosteroids)
Children often present with leukocoria (white pupillary reflex), which may be noticed by parents directly or in photographs. Other presenting signs include strabismus, nystagmus, or poor visual behavior.
A thorough eye examination is essential. This includes:
• Visual assessment (age-appropriate)
• Cycloplegic refraction
• Slit-lamp examination to characterize the cataract
• Fundus examination (if visible)
If the posterior segment cannot be visualized, B-scan ultrasonography is necessary to rule out serious conditions such as Retinoblastoma, retinal detachment, or persistent fetal vasculature.
Laboratory evaluation is guided by clinical suspicion. In bilateral cases, especially with systemic signs, testing may include TORCH titers and metabolic screening (e.g., for galactosemia). Referral to a geneticist is recommended when a syndromic cause is suspected.
The differential diagnosis of leukocoria is broad and includes conditions such as Coats disease, toxocariasis, and retinal detachment, making accurate diagnosis critical.
Management depends on the size, location, and visual significance of the cataract.
• Small (<3 mm), non-central cataracts may be managed conservatively with observation or pharmacologic dilation and occlusion therapy.
• Visually significant cataracts require early surgical removal to prevent amblyopia.
Surgical treatment typically involves lens aspiration, often combined with posterior capsulotomy and anterior vitrectomy in younger children to prevent visual axis opacification. Intraocular lens (IOL) implantation may be performed, though its use in infants under 1–2 years remains controversial. In these cases, contact lenses are often preferred for optical correction.
Postoperative care is critical and includes:
• Refractive correction (glasses or contact lenses)
• Aggressive amblyopia therapy (patching)
• Regular follow-up to monitor visual development
Prognosis depends on several factors, including age at diagnosis, duration of visual deprivation, cataract density, and presence of associated ocular/systemic disease. Early intervention significantly improves visual outcomes.
Complications include:
• Posterior capsule opacification
• Aphakic or pseudophakic glaucoma (may occur years later)
• Retinal detachment
• Infection (endophthalmitis)
• Amblyopia (most critical long-term risk)
Because of the risk of late-onset glaucoma, lifelong monitoring of intraocular pressure is essential, even years after successful cataract surgery.
- Published on
Ophthalmology – Congenital Hyperpigmented Abnormalities of the Fundus
Congenital hyperpigmented fundus lesions are pigmented abnormalities present at birth, differentiated by their appearance, pattern, and location within the retina or choroid. These lesions arise either from the retinal pigment epithelium (RPE) or melanocytes in the choroid and are usually benign, though some carry systemic associations or require monitoring.
Common entities include:
• Grouped pigmentation (“bear tracks”)
• Congenital hypertrophy of the retinal pigment epithelium (CHRPE)
• Combined hamartoma of the retina and RPE
• Choroidal nevi
• Melanocytoma
• Chorioretinal scars (often from intrauterine infection)
Epidemiologically, these lesions vary in frequency. For example, CHRPE occurs in about 5 per 1,000 individuals, while choroidal nevi are relatively common, present in up to 10–13% of the population.
Risk factors depend on the specific lesion. Notably:
• Multiple or bilateral CHRPE lesions may be associated with Familial adenomatous polyposis
• Combined hamartomas may be associated with Neurofibromatosis type 2
Genetically, CHRPE associated with systemic disease is linked to mutations in the APC gene, while combined hamartomas are associated with NF2 gene mutations. Genetic counseling is recommended when these associations are suspected.
Pathophysiologically, hyperpigmentation results from abnormalities in pigment cell development:
• RPE-derived lesions: CHRPE, grouped pigmentation, combined hamartoma
• Melanocyte-derived lesions: choroidal nevus, melanocytoma
Etiologies include genetic mutations, developmental abnormalities, and in some cases inflammatory or infectious causes (e.g., chorioretinal scars from congenital infections).
Some lesions are associated with systemic disease:
• CHRPE → gastrointestinal polyposis syndromes
• Combined hamartoma → central nervous system tumors (NF2)
• Chorioretinal scars → congenital infections affecting the brain
History should assess:
• Prenatal infection exposure
• Family history of colon cancer or neurologic disease
• Neurologic symptoms (e.g., seizures, developmental delay)
• Exposure risks for infections such as Toxoplasmosis
On examination, a dilated fundus exam is essential. Lesions differ in appearance:
• CHRPE: flat, dark, well-demarcated lesions
• Bear tracks: multiple grouped pigmented spots
• Combined hamartoma: elevated lesion with retinal distortion
• Melanocytoma: deeply pigmented lesion often on the optic nerve
Most lesions are asymptomatic and discovered incidentally, though some may affect vision depending on location.
Diagnostic testing is usually minimal. Imaging such as OCT or B-scan may help characterize lesions. MRI may be indicated when systemic associations (e.g., NF2) are suspected.
Management is generally observation, as most lesions are benign. However:
• Choroidal nevi and melanocytomas require serial monitoring for growth or malignant transformation
• Suspicion of systemic disease warrants referral (e.g., gastroenterology for polyposis syndromes, neurology/neurosurgery for NF2)
Follow-up includes periodic examinations with photo documentation to monitor for changes in size or appearance.
Patient education focuses on:
• Awareness of systemic associations
• Importance of follow-up
• Reporting new visual, neurologic, or hearing symptoms
Prognosis is typically excellent for isolated lesions. However, significance lies in recognizing potential systemic disease associations and rare risks of transformation (e.g., nevus to melanoma).
Congenital hyperpigmented fundus lesions are pigmented abnormalities present at birth, differentiated by their appearance, pattern, and location within the retina or choroid. These lesions arise either from the retinal pigment epithelium (RPE) or melanocytes in the choroid and are usually benign, though some carry systemic associations or require monitoring.
Common entities include:
• Grouped pigmentation (“bear tracks”)
• Congenital hypertrophy of the retinal pigment epithelium (CHRPE)
• Combined hamartoma of the retina and RPE
• Choroidal nevi
• Melanocytoma
• Chorioretinal scars (often from intrauterine infection)
Epidemiologically, these lesions vary in frequency. For example, CHRPE occurs in about 5 per 1,000 individuals, while choroidal nevi are relatively common, present in up to 10–13% of the population.
Risk factors depend on the specific lesion. Notably:
• Multiple or bilateral CHRPE lesions may be associated with Familial adenomatous polyposis
• Combined hamartomas may be associated with Neurofibromatosis type 2
Genetically, CHRPE associated with systemic disease is linked to mutations in the APC gene, while combined hamartomas are associated with NF2 gene mutations. Genetic counseling is recommended when these associations are suspected.
Pathophysiologically, hyperpigmentation results from abnormalities in pigment cell development:
• RPE-derived lesions: CHRPE, grouped pigmentation, combined hamartoma
• Melanocyte-derived lesions: choroidal nevus, melanocytoma
Etiologies include genetic mutations, developmental abnormalities, and in some cases inflammatory or infectious causes (e.g., chorioretinal scars from congenital infections).
Some lesions are associated with systemic disease:
• CHRPE → gastrointestinal polyposis syndromes
• Combined hamartoma → central nervous system tumors (NF2)
• Chorioretinal scars → congenital infections affecting the brain
History should assess:
• Prenatal infection exposure
• Family history of colon cancer or neurologic disease
• Neurologic symptoms (e.g., seizures, developmental delay)
• Exposure risks for infections such as Toxoplasmosis
On examination, a dilated fundus exam is essential. Lesions differ in appearance:
• CHRPE: flat, dark, well-demarcated lesions
• Bear tracks: multiple grouped pigmented spots
• Combined hamartoma: elevated lesion with retinal distortion
• Melanocytoma: deeply pigmented lesion often on the optic nerve
Most lesions are asymptomatic and discovered incidentally, though some may affect vision depending on location.
Diagnostic testing is usually minimal. Imaging such as OCT or B-scan may help characterize lesions. MRI may be indicated when systemic associations (e.g., NF2) are suspected.
Management is generally observation, as most lesions are benign. However:
• Choroidal nevi and melanocytomas require serial monitoring for growth or malignant transformation
• Suspicion of systemic disease warrants referral (e.g., gastroenterology for polyposis syndromes, neurology/neurosurgery for NF2)
Follow-up includes periodic examinations with photo documentation to monitor for changes in size or appearance.
Patient education focuses on:
• Awareness of systemic associations
• Importance of follow-up
• Reporting new visual, neurologic, or hearing symptoms
Prognosis is typically excellent for isolated lesions. However, significance lies in recognizing potential systemic disease associations and rare risks of transformation (e.g., nevus to melanoma).
- Published on
Ophthalmology – Conjunctival and Corneal Foreign Bodies
Conjunctival and corneal foreign bodies are among the most common ophthalmic emergencies, typically involving small particles such as metal, dust, or organic material that become lodged in the conjunctiva or cornea. These injuries frequently occur in young males and are often work-related, especially with activities involving power tools or exposure to wind-blown debris. Proper use of protective eyewear is the most effective preventive measure.
Patients usually present with acute eye pain, foreign body sensation, tearing, redness, and photophobia, which are often relieved temporarily by topical anesthetics. A key aspect of history is identifying the mechanism and velocity of injury, as high-velocity injuries (e.g., metal-on-metal) raise concern for a serious intraocular foreign body (IOFB) or globe penetration, which must not be missed.
On examination, findings may include conjunctival injection, eyelid swelling, corneal epithelial defect, or a visible foreign body. Metallic foreign bodies may leave a rust ring, and long-standing foreign bodies can cause inflammation, infection, or corneal necrosis. A careful slit-lamp examination is essential to determine the location and depth of the foreign body. Fluorescein staining helps identify epithelial defects, and the eyelids should always be everted to check for hidden particles. Warning signs such as decreased vision, irregular pupil, hyphema, or shallow/deep anterior chamber should raise suspicion for globe injury or IOFB.
If needed, imaging such as CT scan or ultrasound can help detect intraocular foreign bodies. MRI should be avoided if a metallic foreign body is suspected. A positive Seidel test indicates aqueous leakage and confirms globe penetration.
Treatment begins with careful removal of the foreign body under topical anesthesia using irrigation, a cotton tip, forceps, or a specialized spud. After removal, topical antibiotics (commonly fluoroquinolones) are prescribed to prevent infection. Cycloplegics may be added for associated inflammation, and oral analgesics can be used for pain. Importantly, topical anesthetics should never be prescribed for home use, as they can delay healing and cause corneal damage.
Close follow-up is essential. Conjunctival foreign bodies are typically reviewed in 48–72 hours, while corneal injuries require more frequent follow-up (every 24–48 hours) until healing occurs. The prognosis is generally excellent for superficial injuries, but complications such as infection, inflammation, or corneal scarring can occur if not managed appropriately.
Conjunctival and corneal foreign bodies are among the most common ophthalmic emergencies, typically involving small particles such as metal, dust, or organic material that become lodged in the conjunctiva or cornea. These injuries frequently occur in young males and are often work-related, especially with activities involving power tools or exposure to wind-blown debris. Proper use of protective eyewear is the most effective preventive measure.
Patients usually present with acute eye pain, foreign body sensation, tearing, redness, and photophobia, which are often relieved temporarily by topical anesthetics. A key aspect of history is identifying the mechanism and velocity of injury, as high-velocity injuries (e.g., metal-on-metal) raise concern for a serious intraocular foreign body (IOFB) or globe penetration, which must not be missed.
On examination, findings may include conjunctival injection, eyelid swelling, corneal epithelial defect, or a visible foreign body. Metallic foreign bodies may leave a rust ring, and long-standing foreign bodies can cause inflammation, infection, or corneal necrosis. A careful slit-lamp examination is essential to determine the location and depth of the foreign body. Fluorescein staining helps identify epithelial defects, and the eyelids should always be everted to check for hidden particles. Warning signs such as decreased vision, irregular pupil, hyphema, or shallow/deep anterior chamber should raise suspicion for globe injury or IOFB.
If needed, imaging such as CT scan or ultrasound can help detect intraocular foreign bodies. MRI should be avoided if a metallic foreign body is suspected. A positive Seidel test indicates aqueous leakage and confirms globe penetration.
Treatment begins with careful removal of the foreign body under topical anesthesia using irrigation, a cotton tip, forceps, or a specialized spud. After removal, topical antibiotics (commonly fluoroquinolones) are prescribed to prevent infection. Cycloplegics may be added for associated inflammation, and oral analgesics can be used for pain. Importantly, topical anesthetics should never be prescribed for home use, as they can delay healing and cause corneal damage.
Close follow-up is essential. Conjunctival foreign bodies are typically reviewed in 48–72 hours, while corneal injuries require more frequent follow-up (every 24–48 hours) until healing occurs. The prognosis is generally excellent for superficial injuries, but complications such as infection, inflammation, or corneal scarring can occur if not managed appropriately.
- Published on
Ophthalmology – Conjunctival Melanoma
Conjunctival melanoma is a malignant tumor of the conjunctiva, the mucous membrane covering the white of the eye and inner eyelids. It is typically pigmented (brown or black) but can also be nonpigmented (pink), which can make diagnosis more challenging. This tumor usually develops slowly over months to years and most commonly affects middle-aged to older adults, particularly those of Caucasian background. Although often painless, it can appear as a red, irritated eye due to associated vascularity.
A key feature is its association with primary acquired melanosis (PAM), a flat conjunctival pigmentation that can transform into melanoma over time—especially when atypia is present. Less commonly, conjunctival melanoma may arise from a pre-existing nevus. Clinically, the lesion appears as a nodular or elevated mass with prominent feeder blood vessels, sometimes surrounded by a “wreath” of dilated vessels. It can occur anywhere on the conjunctiva, including the limbus, bulbar surface, fornix, or caruncle, and may be unifocal or multifocal.
Despite its often slow growth, conjunctival melanoma is a serious condition with metastatic potential. It can invade locally into the eye or orbit and spread to regional lymph nodes, lungs, or brain. The overall risk of metastasis is approximately 25%, and mortality is a significant concern. Tumor size and location influence prognosis, with larger and more posterior lesions carrying higher risk.
Diagnosis is primarily clinical, supported by slit-lamp examination and detailed photographic documentation. It is critical to examine all conjunctival surfaces, including under the eyelids, and to assess for associated PAM. Imaging such as anterior segment OCT or MRI may be used if deeper invasion is suspected. Unlike many tumors, incisional biopsy is avoided due to the risk of tumor seeding; instead, management proceeds directly to excision.
The cornerstone of treatment is complete surgical excision using a “no-touch” technique, which minimizes manipulation of the tumor to prevent dissemination. This is combined with cryotherapy to surrounding tissue and treatment of any associated PAM. Additional therapies may include topical chemotherapy agents such as mitomycin C, 5-fluorouracil, or interferon for residual disease. In advanced cases with deeper invasion, radiotherapy or even orbital exenteration may be required.
Close, lifelong follow-up is essential due to the high risk of recurrence and metastasis. Patients are typically monitored every few months initially, then less frequently if stable. Systemic evaluation for metastatic disease—especially involving lymph nodes, lungs, and brain—is a critical component of care.
Prognosis varies. Recurrence rates are relatively high, and metastasis increases over time. However, many patients retain useful vision, especially with early detection and proper treatment. Complications can include vision loss, scarring, dry eye, diplopia, and, in severe cases, need for extensive surgical intervention.
Conjunctival melanoma is a malignant tumor of the conjunctiva, the mucous membrane covering the white of the eye and inner eyelids. It is typically pigmented (brown or black) but can also be nonpigmented (pink), which can make diagnosis more challenging. This tumor usually develops slowly over months to years and most commonly affects middle-aged to older adults, particularly those of Caucasian background. Although often painless, it can appear as a red, irritated eye due to associated vascularity.
A key feature is its association with primary acquired melanosis (PAM), a flat conjunctival pigmentation that can transform into melanoma over time—especially when atypia is present. Less commonly, conjunctival melanoma may arise from a pre-existing nevus. Clinically, the lesion appears as a nodular or elevated mass with prominent feeder blood vessels, sometimes surrounded by a “wreath” of dilated vessels. It can occur anywhere on the conjunctiva, including the limbus, bulbar surface, fornix, or caruncle, and may be unifocal or multifocal.
Despite its often slow growth, conjunctival melanoma is a serious condition with metastatic potential. It can invade locally into the eye or orbit and spread to regional lymph nodes, lungs, or brain. The overall risk of metastasis is approximately 25%, and mortality is a significant concern. Tumor size and location influence prognosis, with larger and more posterior lesions carrying higher risk.
Diagnosis is primarily clinical, supported by slit-lamp examination and detailed photographic documentation. It is critical to examine all conjunctival surfaces, including under the eyelids, and to assess for associated PAM. Imaging such as anterior segment OCT or MRI may be used if deeper invasion is suspected. Unlike many tumors, incisional biopsy is avoided due to the risk of tumor seeding; instead, management proceeds directly to excision.
The cornerstone of treatment is complete surgical excision using a “no-touch” technique, which minimizes manipulation of the tumor to prevent dissemination. This is combined with cryotherapy to surrounding tissue and treatment of any associated PAM. Additional therapies may include topical chemotherapy agents such as mitomycin C, 5-fluorouracil, or interferon for residual disease. In advanced cases with deeper invasion, radiotherapy or even orbital exenteration may be required.
Close, lifelong follow-up is essential due to the high risk of recurrence and metastasis. Patients are typically monitored every few months initially, then less frequently if stable. Systemic evaluation for metastatic disease—especially involving lymph nodes, lungs, and brain—is a critical component of care.
Prognosis varies. Recurrence rates are relatively high, and metastasis increases over time. However, many patients retain useful vision, especially with early detection and proper treatment. Complications can include vision loss, scarring, dry eye, diplopia, and, in severe cases, need for extensive surgical intervention.
- Published on
Ophthalmology – Congenital Pit of the Optic Disc
Congenital pit of the optic disc is a rare developmental anomaly characterized by a small, round, grayish excavation in the optic nerve head. It is usually unilateral and often discovered incidentally during routine examination. However, it can become clinically significant when associated with serous macular detachment, leading to visual symptoms.
The condition is thought to arise from incomplete closure of the embryonic fissure, resulting in a structural defect of the optic nerve head. Fluid dynamics play a key role in its complications. The most widely accepted mechanism suggests that liquefied vitreous fluid enters through the optic pit into the subretinal space, leading to a characteristic two-layered maculopathy: inner retinal schisis and outer retinal detachment. Vitreomacular traction may also contribute to fluid accumulation.
Patients are often asymptomatic if the pit is isolated. When macular involvement occurs, symptoms include blurred vision, metamorphopsia, micropsia, or paracentral scotoma. On examination, the pit appears as a small hypopigmented depression, most commonly located on the temporal side of the optic disc. Visual field defects, particularly arcuate scotomas, may be present. Up to 40–50% of cases develop serous macular detachment, especially with larger or temporally located pits.
Diagnosis is primarily clinical but supported by imaging. Optical coherence tomography (OCT) is essential and typically shows schisis-like separation of retinal layers with subretinal fluid. Fluorescein angiography is usually unremarkable but may show late staining of the pit. Visual field testing helps document functional deficits.
Management depends on the presence of complications. Asymptomatic pits require observation with regular follow-up. In cases with serous macular detachment, treatment options include laser photocoagulation, pars plana vitrectomy with internal tamponade, and sometimes macular buckling. Among these, vitrectomy with induction of posterior vitreous detachment has shown the most favorable long-term outcomes.
The prognosis is variable. While the optic pit itself is typically stable, associated macular detachment can lead to progressive visual loss. Many patients experience significant decline in visual acuity over time, although rare cases of spontaneous resolution have been reported. The main complication is serous macular detachment, which is responsible for most visual morbidity.
Congenital pit of the optic disc is a rare developmental anomaly characterized by a small, round, grayish excavation in the optic nerve head. It is usually unilateral and often discovered incidentally during routine examination. However, it can become clinically significant when associated with serous macular detachment, leading to visual symptoms.
The condition is thought to arise from incomplete closure of the embryonic fissure, resulting in a structural defect of the optic nerve head. Fluid dynamics play a key role in its complications. The most widely accepted mechanism suggests that liquefied vitreous fluid enters through the optic pit into the subretinal space, leading to a characteristic two-layered maculopathy: inner retinal schisis and outer retinal detachment. Vitreomacular traction may also contribute to fluid accumulation.
Patients are often asymptomatic if the pit is isolated. When macular involvement occurs, symptoms include blurred vision, metamorphopsia, micropsia, or paracentral scotoma. On examination, the pit appears as a small hypopigmented depression, most commonly located on the temporal side of the optic disc. Visual field defects, particularly arcuate scotomas, may be present. Up to 40–50% of cases develop serous macular detachment, especially with larger or temporally located pits.
Diagnosis is primarily clinical but supported by imaging. Optical coherence tomography (OCT) is essential and typically shows schisis-like separation of retinal layers with subretinal fluid. Fluorescein angiography is usually unremarkable but may show late staining of the pit. Visual field testing helps document functional deficits.
Management depends on the presence of complications. Asymptomatic pits require observation with regular follow-up. In cases with serous macular detachment, treatment options include laser photocoagulation, pars plana vitrectomy with internal tamponade, and sometimes macular buckling. Among these, vitrectomy with induction of posterior vitreous detachment has shown the most favorable long-term outcomes.
The prognosis is variable. While the optic pit itself is typically stable, associated macular detachment can lead to progressive visual loss. Many patients experience significant decline in visual acuity over time, although rare cases of spontaneous resolution have been reported. The main complication is serous macular detachment, which is responsible for most visual morbidity.
- Published on
Ophthalmology – Corneal Abrasion
A corneal abrasion is a defect in the corneal epithelium, most commonly caused by trauma, though it can also occur due to underlying epithelial adhesion problems or corneal dystrophies. It is one of the most frequent ophthalmic presentations and is typically very painful despite being a superficial injury.
The most common cause is mechanical trauma, such as fingernails, paper cuts, foreign bodies, or contact lenses. Contact lens wearers and individuals in high-risk occupations (e.g., construction, welding) are particularly vulnerable. Nontraumatic causes include recurrent corneal erosion, often due to poor adhesion between the epithelium and underlying basement membrane, especially after prior injury or in conditions like map-dot-fingerprint dystrophy.
Patients usually present with sudden onset of severe eye pain, foreign body sensation, redness, tearing, and photophobia. Pain typically worsens with blinking and improves when the eye is closed. Many patients can clearly recall the inciting event. In recurrent cases, symptoms often occur upon awakening, when the eyelid disrupts loosely adherent epithelium.
Diagnosis is confirmed with fluorescein staining under cobalt blue light, which highlights the epithelial defect as a bright green area. The abrasion is typically irregular in shape, and its size should be documented for follow-up. Vertical linear staining suggests a foreign body under the upper eyelid, which must be ruled out by lid eversion. The underlying corneal stroma should remain clear—any infiltrate raises concern for infection.
Management focuses on pain control, prevention of infection, and promoting healing. First-line treatment includes topical antibiotic drops or ointment (e.g., erythromycin or fluoroquinolones) to prevent secondary infection. Ointments provide better lubrication and comfort. Topical NSAIDs and cycloplegics can be used for pain and photophobia. Importantly, topical anesthetics must never be prescribed for home use, as they delay healing and can cause serious complications.
For recurrent corneal erosions, long-term therapy with lubricating drops, ointments, and hypertonic saline (e.g., 5% NaCl) helps improve epithelial adhesion. In refractory cases, procedures such as anterior stromal puncture or phototherapeutic keratectomy (PTK) may be considered.
Patching is generally not required for small abrasions and should be avoided if infection is suspected, especially in contact lens wearers, where the risk of bacterial keratitis is higher. Contact lenses should not be worn until complete healing occurs.
The prognosis is excellent, with most abrasions healing within 24–72 hours. However, complications can occur if untreated or mismanaged, including infectious keratitis, corneal ulceration, and recurrent erosions. Close follow-up is essential until the epithelial defect has fully healed.
A corneal abrasion is a defect in the corneal epithelium, most commonly caused by trauma, though it can also occur due to underlying epithelial adhesion problems or corneal dystrophies. It is one of the most frequent ophthalmic presentations and is typically very painful despite being a superficial injury.
The most common cause is mechanical trauma, such as fingernails, paper cuts, foreign bodies, or contact lenses. Contact lens wearers and individuals in high-risk occupations (e.g., construction, welding) are particularly vulnerable. Nontraumatic causes include recurrent corneal erosion, often due to poor adhesion between the epithelium and underlying basement membrane, especially after prior injury or in conditions like map-dot-fingerprint dystrophy.
Patients usually present with sudden onset of severe eye pain, foreign body sensation, redness, tearing, and photophobia. Pain typically worsens with blinking and improves when the eye is closed. Many patients can clearly recall the inciting event. In recurrent cases, symptoms often occur upon awakening, when the eyelid disrupts loosely adherent epithelium.
Diagnosis is confirmed with fluorescein staining under cobalt blue light, which highlights the epithelial defect as a bright green area. The abrasion is typically irregular in shape, and its size should be documented for follow-up. Vertical linear staining suggests a foreign body under the upper eyelid, which must be ruled out by lid eversion. The underlying corneal stroma should remain clear—any infiltrate raises concern for infection.
Management focuses on pain control, prevention of infection, and promoting healing. First-line treatment includes topical antibiotic drops or ointment (e.g., erythromycin or fluoroquinolones) to prevent secondary infection. Ointments provide better lubrication and comfort. Topical NSAIDs and cycloplegics can be used for pain and photophobia. Importantly, topical anesthetics must never be prescribed for home use, as they delay healing and can cause serious complications.
For recurrent corneal erosions, long-term therapy with lubricating drops, ointments, and hypertonic saline (e.g., 5% NaCl) helps improve epithelial adhesion. In refractory cases, procedures such as anterior stromal puncture or phototherapeutic keratectomy (PTK) may be considered.
Patching is generally not required for small abrasions and should be avoided if infection is suspected, especially in contact lens wearers, where the risk of bacterial keratitis is higher. Contact lenses should not be worn until complete healing occurs.
The prognosis is excellent, with most abrasions healing within 24–72 hours. However, complications can occur if untreated or mismanaged, including infectious keratitis, corneal ulceration, and recurrent erosions. Close follow-up is essential until the epithelial defect has fully healed.
